NCT02866032View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

PHASE3CompletedINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 10, 2020

Study Completion Date

June 10, 2020

Conditions
Distal Subungual Onychomycosis
Interventions
DRUG

MOB015B

DRUG

Ciclopirox 80 mg/g

Trial Locations (3)

Unknown

Multiple Locations

Multiple Locations

Multiple Locations

Sponsors

Lead Sponsor

Moberg Pharma AB
All Listed Sponsors
lead

Moberg Pharma AB

INDUSTRY